scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0166-3542(85)80006-1 |
P698 | PubMed publication ID | 3002264 |
P2093 | author name string | S Shigeta | |
T Yokota | |||
E De Clercq | |||
P2860 | cites work | In vitro susceptibility of varicella-zoster virus to E-5-(2-bromovinyl)-2'-deoxyuridine and related compounds | Q28366155 |
Live vaccine used to prevent the spread of varicella in children in hospital | Q34202755 | ||
On the mechanism of selective inhibition of herpesvirus replication by (E)-5-(2-bromovinyl)-2'-deoxyuridine | Q35358460 | ||
Human Leukocyte Interferon for the Treatment of Herpes Zoster in Patients with Cancer | Q40882180 | ||
Varicella-zoster virus DNA in human sensory ganglia | Q41558362 | ||
Comparative efficacy of antiherpes drugs against various strains of varicella-zoster virus | Q45798707 | ||
Varicella-zoster virus RNA in human trigeminal ganglia | Q45806233 | ||
Herpes zoster and varicella infections in children with hodgkin's disease.An analysis of contributing factors | Q67274164 | ||
Evaluation of Varicella-Zoster Immune Globulin: Protection of Immunosuppressed Children after Household Exposure to Varicella | Q70251636 | ||
Transfer Factor for the Prevention of Varicella-Zoster Infection in Childhood Leukemia | Q72856973 | ||
P304 | page(s) | 35-44 | |
P577 | publication date | 1985-01-01 | |
P1433 | published in | Antiviral Research | Q4775352 |
P1476 | title | Therapy of varicella-zoster virus infection--mechanism of action of (E)-5-(2-bromovinyl)-2'-deoxyuridine | |
P478 | volume | Suppl 1 |
Search more.